US Home - Resources and whitepapers - Whitepapers - Comparison of Vanco Ready® Vancomycin Injection Premix with Lyophilized Vancomycin Products in a Simulated Compounding & Clinical Setting

Comparison of Vanco Ready® Vancomycin Injection Premix with Lyophilized Vancomycin Products in a Simulated Compounding & Clinical Setting

Authors

Alexander James Sperry, James Cruikshank, Huong Hoang, Kato Nicholes, George Edward MacKinnon III, Nashaat Zakaria Gerges, Abhay Singh Chauhan.

Summary

This study aimed to compare Xellia Pharmaceuticals’ Vanco Ready® Vancomycin Injection, a premix, room-temperature stable vancomycin IV formulation, with compounded lyophilized vancomycin in a simulated sterile compounding setting, to assess dispensing time and dosing accuracy.

You can download the whitepaper by clicking the link below.

 

Download this whitepaper (PDF)

You are about to be redirected to Xellia’s global website

We are now redirecting you to our global website, click ‘confirm’ below to continue or ‘cancel’ and we will return you to your previous page.

Cancel Confirm